# Molnlycke Health Care AB clinical trials: 59 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 59 trials with Molnlycke Health Care AB as lead sponsor, 6 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Molnlycke Health Care AB: 59 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/molnlycke-health-care-ab

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 59
- Recruiting or not yet: 6
- Read on: November 19, 2026

## Trials

The 25 newest of 59, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2026 | NCT07926386 | Interventional Study to Describe the Utilization of Foam Dressings in Routine Clinical Practice, for the Treatment of Patients With Chronic... | Molnlycke Health Care AB | Not applicable | Recruiting | Chronic Wound Care | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926386) |
| August 24, 2026 | NCT07782008 | Performance and Safety of Mepilex® Up in Leg and Foot Ulcers and Skin Tears | Molnlycke Health Care AB | Not applicable | Not yet recruiting | Leg Ulcer, Pressure Ulcer (PU), Skin Tears, Foot Ulcer, Diabetic Foot Ulcer | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782008) |
| May 20, 2026 | NCT07600489 | A Randomized Non-Inferiority Study of Mepi™ Press 2 vs UrgoK2® for Compression Therapy in Venous Leg Ulcers | Molnlycke Health Care AB | Not applicable | Not yet recruiting | Venous Leg Ulcer (VLU), Compression Bandages | 386 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07600489) |
| June 24, 2025 | NCT07034014 | An Investigation to Evaluate Wearing Properties of Three Different Investigational Devices | Molnlycke Health Care AB | Not applicable | Recruiting | Healthy Volunteer Study | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07034014) |
| October 28, 2024 | NCT06661473 | Interventional Study Exploring the Occurrence of Surgical Site Infections. | Molnlycke Health Care AB | Not applicable | Completed | Total Knee Arthroplasty, Total Hip Arthroplasty Revision, Total Knee Arthroplasty Revision | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06661473) |
| April 30, 2024 | NCT06392165 | Evaluation of Adhesion Properties in Wound Care Devices | Molnlycke Health Care AB | Not applicable | Unknown | Adhesion Properties of Wound Care Devices | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06392165) |
| March 20, 2024 | NCT06321978 | Mepilex Border Flex Utilization Pilot Spain | Molnlycke Health Care AB | Observational | Unknown | Wound | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06321978) |
| November 8, 2022 | NCT05608317 | A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing | Molnlycke Health Care AB | Not applicable | Recruiting | Wounds, Wound of Skin, Wound Leg, Venous Leg Ulcer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05608317) |
| October 20, 2022 | NCT05588583 | A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing. | Molnlycke Health Care AB | Not applicable | Recruiting | Wounds, Wound of Skin, Wound Leg, Wound; Foot, Diabetic Foot Ulcer, Venous Leg Ulcer | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05588583) |
| August 10, 2022 | NCT05494450 | An Open, Non-comparative, Multicenter Investigation to Evaluate the Safety and Performance of Exufiber Ag+, a Gelling Fiber Silver... | Molnlycke Health Care AB | Not applicable | Terminated | Pressure Ulcer, Diabetic Foot Ulcer, Venous Leg Ulcer | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05494450) |
| August 6, 2021 | NCT04994145 | A Post-Market Clinical Investigation on Mepilex Border Post-Op | Molnlycke Health Care AB | Observational | Unknown | Surgical Wound | 560 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04994145) |
| July 14, 2021 | NCT04960553 | A PMCF Investigation on Exuding Chronic Wounds Using Exufiber® as Primary Dressing, and Mepilex® Border Flex/Comfort | Molnlycke Health Care AB | Not applicable | Terminated | Wound Heal | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04960553) |
| June 28, 2021 | NCT04942496 | A 96-hour Patch Test Study Using Healthy Human Volunteers to Assess the Skin Irritation Potential of 11 Topically Applied Formulations | Molnlycke Health Care AB | Phase 4 | Unknown | Skin Irritancy Potential | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04942496) |
| May 20, 2021 | NCT04894604 | A Safety and Performance PMCF Investigation of the Avance® Solo NPWT System in Surgically Closed Incisions | Molnlycke Health Care AB | Not applicable | Unknown | Incision, Surgical, Surgical Incision, Surgical Wound, Surgical Wound, Recent, Surgical Wound Dehiscence | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04894604) |
| May 13, 2021 | NCT04884568 | Confirm Performance and Safety of Exufiber When Used as Intended on Donor Sites | Molnlycke Health Care AB | Not applicable | Completed | Acute Wound, Donor Site, Split Skin Graft | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04884568) |
| April 9, 2021 | NCT04839523 | Performance and Safety of Exufiber Ag+ and Exufiber on Partial Thickness Burns | Molnlycke Health Care AB | Not applicable | Active not recruiting | Partial-thickness Burn | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04839523) |
| March 24, 2021 | NCT04813809 | A Clinical Investigation With BARRIER® EasyWarm® | Molnlycke Health Care AB | Not applicable | Completed | Healthy Volunteers | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04813809) |
| February 15, 2021 | NCT04754048 | Confirm the Safety and Performance of Avance Solo NPWT System | Molnlycke Health Care AB | Not applicable | Completed | Acute Wound, Traumatic Wound, Skin Graft, Skin Flap, Subacute Wound, Dehiscence | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04754048) |
| February 15, 2021 | NCT04753294 | Confirm Safety and Performance of Avance Solo and Avance Solo Adapt NPWT Systems | Molnlycke Health Care AB | Not applicable | Completed | Venous Leg Ulcer, Pressure Ulcer, Diabetic Foot Ulcer, Chronic Ulcer | 136 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04753294) |
| December 4, 2020 | NCT04654182 | Evaluation of the Residual Antimicrobial Efficacy of One Test Material Based on a Modification of ASTM E1115-11 Test Method | Molnlycke Health Care AB | Phase 4 | Completed | Hand Hygiene | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04654182) |
| January 22, 2020 | NCT04235985 | Evaluation of Chlorhexidine Gluconate Concentration on Skin of Human Subjects Following Multiple Application Times | Molnlycke Health Care AB | Phase 4 | Completed | General Skin Cleansing | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04235985) |
| November 29, 2019 | NCT04181320 | A Multicentre European Study to Evaluate Granulox® Used in the Treatment Pathway of Predominantly Chronic Venous Leg Ulcers (VLUs). | Molnlycke Health Care AB | Not applicable | Terminated | Venous Leg Ulcer | 128 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04181320) |
| November 13, 2018 | NCT03738163 | A Clinical Investigation With Epaderm® Cream | Molnlycke Health Care AB | Not applicable | Completed | Eczema, Psoriasis, Dry Skin; Eczema | 121 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03738163) |
| September 10, 2018 | NCT03662997 | Clinical Study to Compare 3 Multi-Layered Foam Dressings for the Management of Chronic Wounds | Molnlycke Health Care AB | Not applicable | Completed | Chronic Wound, Venous Leg Ulcer, Diabetic Foot Ulcer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03662997) |
| November 17, 2017 | NCT03344354 | Durability of Double-gloving With Biogel® Surgical Gloves When Used by Clinicians/Surgeons | Molnlycke Health Care AB | Not applicable | Completed | Gloves, Surgical | 3,507 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03344354) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 2 | 1 |
| Phase 2/3 | 1 |
| Phase 3 | 1 |
| Phase 4 | 7 |
| Not applicable | 46 |
| Observational | 3 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 41 |
| Unknown | 5 |
| Terminated | 5 |
| Recruiting | 4 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
| Active not recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Varicose Ulcer | 9 |
| Diabetic Foot | 9 |
| Pressure Ulcer | 6 |
| Wounds and Injuries | 6 |
| Burns | 5 |
| Surgical Wound | 2 |
| Pain | 2 |
| Leg Ulcer | 2 |
| Foot Ulcer | 2 |
| Inflammation | 1 |
| Ulcer | 1 |
| Critical Illness | 1 |
| Foot Injuries | 1 |
| Diabetes Mellitus | 1 |
| Surgical Wound Dehiscence | 1 |
| Eczema | 1 |
| Psoriasis | 1 |
| Knee Injuries | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Allergy and immunology practices in the United States](https://specstream.ai/data/businesses/allergy-and-immunology-practices/united-states)
- [Engineering schools in the United States](https://specstream.ai/data/businesses/engineering-schools/united-states)
- [Oral and maxillofacial surgery practices in the United States](https://specstream.ai/data/businesses/oral-and-maxillofacial-surgery-practices/united-states)
- [Welding supply stores in the United States](https://specstream.ai/data/businesses/welding-supply-stores/united-states)
- [Drama schools in the United States](https://specstream.ai/data/businesses/drama-schools/united-states)
- [Metal suppliers in the United States](https://specstream.ai/data/businesses/metal-suppliers/united-states)
